oncovirx.com

Home -OncoViRx

OncoViRx is a discovery-stage, pharmaceutical start-up within the University of Pennsylvanias UPstart program.
traffic

OVERVIEW

This site oncovirx.com presently has a traffic classification of zero (the lower the more users). We have researched seven pages within the web page oncovirx.com and found one website referencing oncovirx.com.
Pages Analyzed
7
Links to this site
1

ONCOVIRX.COM RANKINGS

This site oncovirx.com is seeing fluctuating levels of traffic all through the year.
Traffic for oncovirx.com

Date Range

1 week
1 month
3 months
This Year
Last Year
All time
Traffic ranking (by month) for oncovirx.com

Date Range

All time
This Year
Last Year
Traffic ranking by day of the week for oncovirx.com

Date Range

All time
This Year
Last Year
Last Month

LINKS TO BUSINESS

Home Page - Penn Center for Innovation

Empowering Penn discoveries and ideas. Learn the technology transfer process, disclose an invention, submit a contract, apply for the PCI Fellows program. Engage with PCI, browse Penn-owned technologies available for licensing, review leading innovation centers. Learn more about Penn Center for Innovation.

WHAT DOES ONCOVIRX.COM LOOK LIKE?

Desktop Screenshot of oncovirx.com Mobile Screenshot of oncovirx.com Tablet Screenshot of oncovirx.com

ONCOVIRX.COM HOST

We caught that the main root page on oncovirx.com took ten thousand four hundred and thirty-seven milliseconds to come up. I could not discover a SSL certificate, so in conclusion we consider this site not secure.
Load time
10.437 seconds
SSL
NOT SECURE
Internet Address
107.180.50.244

BOOKMARK ICON

SERVER OPERATING SYSTEM

I discovered that this domain is implementing the Apache/2.4.23 os.

TITLE

Home -OncoViRx

DESCRIPTION

OncoViRx is a discovery-stage, pharmaceutical start-up within the University of Pennsylvanias UPstart program.

CONTENT

This site had the following in the web page, "Our Pipeline Small Molecule Inhibitors." Our analyzers observed that the web page stated " Targeted small molecule therapy for difficult-to-treat hematologic malignancies." The Website also stated " B, and Notch1 pathways, and anticipate initial clinical development will be in several sub-types of relapsedrefractory non-Hodgkins lymphoma andor acute myeloid leukemia. Approximately every 3 minutes one person in the United States is diagnosed with a blood cancer. Approximately every 10 minutes one person in the United States dies from a blood cancer."

MORE WEB PAGES

Penzymes LLC - Home

To block the local formation of steroid hormones in hormone dependent maligancies of the prostate, breast and endometrium. An area of huge unmet clinical need.

PolyAurum Gold nanoparticles to safely diagnose and treat disease

Gold nanoparticles to safely diagnose and treat disease. Enhancement of radiotherapy with BNGPs has the potential to increase cancer-free survival and improve patient quality of life. PolyAurum Selected as a Featured Company at IMPACT 2016 Capital Conference. PolyAurum Technology Featured at ACS Fall Meeting.

The-3D--xs blog - Cest nous les meilleures lL - Skyrock.com

Et quand se sera le moment de se quitter . Please enter the sequence of characters in the field below.

Ventilando a Net

CLIQUE NO NOSSO PARCEIRO PARA AJUDAR. Sábado, 7 de janeiro de 2012. Nossa Descubra o que ela faz. Foto Doida e Loca da Net. Terça-feira, 3 de janeiro de 2012. Fotos Loucas e Retardadas da Web. Sábado, 31 de dezembro de 2011. Cada foto conta uma historia. Coisas da Internet em Fotos.